Anzeige
Erschienen in:
23.10.2017 | Original Article
Geisinger high-risk osteoporosis clinic (HiROC): 2013–2015 FLS performance analysis
Erschienen in: Osteoporosis International | Ausgabe 2/2018
Einloggen, um Zugang zu erhaltenAbstract
Summary
Geisinger Health System (GHS) high-risk osteoporosis clinic (HiROC), which treats patients with low-trauma, fragility fractures, reports their 2013–2015 performance measures in secondary fracture prevention. This fracture liaison service (FLS) pathway treats 75% of high-risk, drug eligible patients, compared to 13.8% in GHS primary care. This performance points to the need for more FLS programs throughout the world.
Introduction
The purpose of this study is to analyze and report ongoing performance measures in outpatient and inpatient high-risk osteoporosis clinic (HiROC) program designed for patients with low-trauma, fragility fractures.
Methods
Retrospective chart review of outpatient HiROC (511 patients) and inpatient HiROC (1279 patients) performance from 2013 to 2015 is reported within Geisinger Health System (GHS).
Results
Similar to a prior report, we document that Geisinger’s branded outpatient and inpatient HiROC pathways continue to function as an all-fracture FLS. Importantly, this analysis emphasizes the importance of FLS care that HiROC’s treatment rate of 75% was markedly superior to GHS-PCP care of 13.8%. However, a large percentage of patients (37.8%) were lost to follow-up care. This led to the identification of multiple care gaps/barriers to ideal best practice.
Conclusions
FLS programs use case finding strategies and address secondary fracture prevention. GHS HiROC’s performance and initiation of drug therapy in this fracture patient population contrasts with GHS-PCP care’s much lower rate of treatment, documenting the need for ongoing FLS care. Importantly, the results of this analysis have prompted the beginnings of GHS programmatic changes, designed to narrow the reported care gaps in this mature FLS.